GO:0061598 molybdopterin adenylyltransferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0061598 defines the catalytic activity that transfers an adenylate group from ATP to molybdopterin, forming adenylyl-molybdopterin and diphosphate.
• This reaction is an essential step in molybdenum cofactor (Moco) biosynthesis, enabling insertion of molybdenum into the cofactor.
• In humans, the enzyme responsible for this activity is MOCS3 (also known as UBA4), a bifunctional protein with a C-terminal rhodanese-like domain and an N-terminal adenylation domain.
• Defects in Moco biosynthesis cause molybdenum cofactor deficiency, a severe metabolic disorder with neonatal seizures and neurodegeneration.
• The adenylyltransferase activity is conserved from bacteria to humans and is mechanistically related to other adenylyltransferases such as FAD synthase.
• Research tools include CRISPR knockout, point-mutation, knock-in, and overexpression models, combined with metabolomics and enzyme assays.
Description
Molybdenum cofactor (Moco) is a prosthetic group required for the activity of several essential enzymes, including sulfite oxidase, xanthine dehydrogenase, and aldehyde oxidase. The biosynthesis of Moco involves a series of conserved steps, one of which is the adenylation of molybdopterin to form adenylyl-molybdopterin. This reaction is catalyzed by molybdopterin adenylyltransferase (GO:0061598), an enzymatic activity that activates molybdopterin for subsequent molybdenum insertion. In humans, the enzyme responsible for this activity is MOCS3, a bifunctional protein that also participates in sulfur transfer for Moco biosynthesis. Understanding this activity is crucial because mutations in Moco biosynthesis genes lead to molybdenum cofactor deficiency, a devastating disorder characterized by severe neurological symptoms. Moreover, the adenylyltransferase mechanism shares structural and functional similarities with other adenylyltransferases, such as FAD synthase, providing insights into a broader family of enzymes. This article reviews the definition, mechanism, key genes, and research methods for studying molybdopterin adenylyltransferase activity.
molybdopterin adenylyltransferase activity At A Glance
| GO ID | GO:0061598 |
|---|---|
| GO term | molybdopterin adenylyltransferase activity |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Catalyzes the adenylation of molybdopterin to form adenylyl-molybdopterin, an essential step in molybdenum cofactor biosynthesis. |
| Reaction | ATP + molybdopterin = diphosphate + adenylyl-molybdopterin. |
| Human gene | MOCS3 (UBA4) encodes the enzyme with this activity. |
| Pathway | Molybdenum cofactor biosynthesis. |
| Disease relevance | Defects in Moco biosynthesis cause molybdenum cofactor deficiency. |
What Is GO:0061598?
Molybdopterin adenylyltransferase activity (GO:0061598) is defined as the catalysis of the reaction ATP + molybdopterin = diphosphate + adenylyl-molybdopterin. In other words, it is the enzyme activity that attaches an adenosine monophosphate (AMP) moiety to molybdopterin, using ATP as the donor and releasing pyrophosphate. This modification is a prerequisite for the subsequent insertion of molybdenum into the cofactor, which is essential for the function of Moco-dependent enzymes.
Why Is molybdopterin adenylyltransferase activity Important in Cell Biology?
Molybdopterin adenylyltransferase activity is a critical step in the biosynthesis of the molybdenum cofactor, which is required for the activity of enzymes involved in purine metabolism, sulfite detoxification, and neurotransmitter synthesis. Without this activity, molybdopterin cannot be adenylated, molybdenum cannot be inserted, and Moco-dependent enzymes remain inactive. This leads to the accumulation of toxic metabolites such as sulfite, causing severe neurological damage in humans. Therefore, understanding this activity is essential for diagnosing and potentially treating Moco deficiency disorders, and for biotechnological applications requiring Moco-dependent enzymes.
• Essential for molybdenum cofactor biosynthesis and activation of Moco-dependent enzymes.
• Defects cause molybdenum cofactor deficiency, a rare but severe metabolic disorder with neonatal seizures and brain atrophy.
• The reaction is conserved across species, from bacteria to humans.
• MOCS3, the human enzyme, is bifunctional, linking adenylyltransferase activity to sulfur transfer.
• The mechanism is similar to other adenylyltransferases, such as FAD synthase, providing a model for enzyme evolution.
• Inhibiting this activity could be a strategy for developing antimicrobials targeting bacterial Moco biosynthesis.
• Enhancing this activity may improve production of Moco-dependent enzymes in biotechnology.
• Research on this activity helps understand the broader family of NTP-dependent adenylyltransferases.
Molecular Mechanism of molybdopterin adenylyltransferase activity
Substrate Binding and Activation
In simple terms: The enzyme grabs molybdopterin and ATP to start the reaction.
Molybdopterin adenylyltransferase binds its substrates, molybdopterin and ATP, in a sequential manner. The enzyme likely uses a conserved motif to coordinate the phosphate groups of ATP and the hydroxyl groups of molybdopterin, positioning them for catalysis. Structural studies of related enzymes suggest that a divalent metal ion, such as Mg2+, may be required for ATP binding and stabilization.
Catalytic Transfer of Adenylate
In simple terms: The enzyme transfers an AMP group from ATP onto molybdopterin.
The catalytic mechanism involves the nucleophilic attack of a hydroxyl group of molybdopterin on the alpha-phosphate of ATP, resulting in the formation of adenylyl-molybdopterin and the release of diphosphate. This reaction is analogous to the adenylylation step in FAD synthase, where FMN is adenylated to form FAD. The enzyme likely employs general acid-base catalysis, with conserved residues facilitating the departure of the diphosphate leaving group.
Product Release and Coupling to Molybdenum Insertion
In simple terms: After the reaction, the product is used to insert molybdenum into the cofactor.
Following the adenylation of molybdopterin, the product adenylyl-molybdopterin is released from the enzyme and serves as a substrate for the next step in Moco biosynthesis, where molybdenum is inserted by the enzyme MOCS2 (molybdopterin synthase) and other factors. This step is essential for the formation of the active molybdenum cofactor.
Bifunctional Nature of MOCS3
In simple terms: The human enzyme has two jobs: adenylation and sulfur transfer.
In humans, the enzyme with molybdopterin adenylyltransferase activity is MOCS3, which is a bifunctional protein. Its N-terminal domain catalyzes the adenylation of molybdopterin, while its C-terminal rhodanese-like domain is involved in sulfur transfer for the synthesis of the molybdopterin dithiolene moiety. This dual function ensures efficient coordination of the two steps in Moco biosynthesis.
Regulation and Cofactor Requirements
In simple terms: The enzyme needs specific conditions and cofactors to work.
The activity of molybdopterin adenylyltransferase is dependent on the presence of divalent cations, particularly Mg2+, which is required for ATP binding. The enzyme may also be regulated by the availability of its substrates, molybdopterin and ATP, which are produced by upstream enzymes in the Moco pathway. Additionally, the redox state of the cell could influence the activity, as Moco biosynthesis is sensitive to oxidative stress.
Key Genes Involved in GO:0061598 molybdopterin adenylyltransferase activity
The following genes and proteins are directly involved in molybdopterin adenylyltransferase activity or its associated pathways.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MOCS3 (UBA4) | Human molybdopterin adenylyltransferase; catalyzes adenylation of molybdopterin | Target for studying Moco deficiency and enzyme mechanism |
| MOCS1 | Involved in the first step of Moco biosynthesis, converting GTP to cyclic pyranopterin monophosphate | Mutations cause Moco deficiency type A |
| MOCS2 | Molybdopterin synthase; catalyzes the formation of molybdopterin from cPMP | Mutations cause Moco deficiency type B |
| GEPH (GPHN) | Gephyrin; involved in Moco biosynthesis and molybdenum insertion | Mutations cause Moco deficiency type C |
| SUOX | Sulfite oxidase; Moco-dependent enzyme | Deficiency causes isolated sulfite oxidase deficiency |
| XDH | Xanthine dehydrogenase; Moco-dependent enzyme | Deficiency causes xanthinuria |
| AOX1 | Aldehyde oxidase; Moco-dependent enzyme | Involved in drug metabolism |
| NFS1 | Cysteine desulfurase; provides sulfur for Moco biosynthesis | Supports MOCS3 sulfur transfer function |
| TUM1 (TRMU) | Sulfurtransferase; interacts with MOCS3 | Potential regulator of MOCS3 activity |
| FAD synthase (FLAD1) | Bifunctional enzyme with adenylyltransferase activity similar to MOCS3 | Model for studying adenylyltransferase mechanism |
| MOCS3 homologs in bacteria (e.g., MoaD, MoeB) | Bacterial counterparts of MOCS3 involved in Moco biosynthesis | Antimicrobial target exploration |
| ATP | Substrate for adenylyltransferase reaction | Cofactor in enzyme assays |
| Molybdopterin | Substrate for adenylyltransferase reaction | Metabolite in Moco pathway |
| Adenylyl-molybdopterin | Product of the reaction | Intermediate in Moco biosynthesis |
| Magnesium (Mg2+) | Cofactor required for ATP binding | Essential for in vitro activity assays |
| MOCS3 (UBA4) mutants | Altered activity variants | Used to study structure-function relationships |
How Is molybdopterin adenylyltransferase activity Regulated?
The activity of molybdopterin adenylyltransferase is primarily regulated by the availability of its substrates, molybdopterin and ATP, which are synthesized in upstream steps of the Moco pathway. Additionally, the expression of MOCS3 may be controlled at the transcriptional level in response to cellular demands for Moco. Post-translational modifications, such as phosphorylation, could potentially regulate MOCS3 activity, but this remains to be fully elucidated. The bifunctional nature of MOCS3 suggests that its adenylyltransferase activity might be coordinated with its sulfur transfer function to ensure efficient Moco biosynthesis.
molybdopterin adenylyltransferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MOCS3 | Molybdenum cofactor deficiency (rare) | CRISPR knockout in HEK293 cells; rescue with wild-type or mutant MOCS3 |
| MOCS1 | Molybdenum cofactor deficiency type A | Patient-derived fibroblasts; iPSC-derived neurons |
| MOCS2 | Molybdenum cofactor deficiency type B | Knockout mouse models |
| GPHN | Molybdenum cofactor deficiency type C | Zebrafish models; CRISPR knockout |
| SUOX | Isolated sulfite oxidase deficiency | Patient fibroblasts; enzyme activity assays |
Molybdenum Cofactor Deficiency
Molybdenum cofactor deficiency is a rare autosomal recessive disorder caused by mutations in genes involved in Moco biosynthesis, including MOCS3. Patients typically present with neonatal seizures, severe neurological deterioration, and brain atrophy due to the accumulation of sulfite and other toxic metabolites. While mutations in MOCS3 specifically are rare, loss of its adenylyltransferase activity would block Moco synthesis, leading to a similar phenotype. Diagnosis is based on biochemical findings such as elevated sulfite in urine and low uric acid.
Sulfite Oxidase Deficiency
Isolated sulfite oxidase deficiency is a condition that mimics Moco deficiency but is caused by mutations in the SUOX gene, which encodes a Moco-dependent enzyme. Although not directly caused by defects in molybdopterin adenylyltransferase, this disorder highlights the importance of Moco biosynthesis for sulfite oxidase activity. Understanding the adenylyltransferase step could inform therapeutic strategies for both conditions.
Xanthinuria
Xanthinuria is a metabolic disorder caused by deficiency of xanthine dehydrogenase, another Moco-dependent enzyme. While not directly linked to molybdopterin adenylyltransferase activity, it underscores the broad impact of Moco biosynthesis on purine metabolism. Research into the adenylyltransferase could provide insights into the regulation of Moco-dependent enzymes.
From molybdopterin adenylyltransferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of MOCS3 adenylyltransferase activity cause Moco deficiency? | CRISPR knockout of MOCS3 in human cell lines (e.g., HEK293) |
| What is the effect of a specific point mutation in the catalytic domain of MOCS3? | Point-mutation knock-in via CRISPR in cell lines |
| Can wild-type MOCS3 rescue the phenotype of MOCS3 knockout cells? | Knock-in of wild-type MOCS3 cDNA under a constitutive promoter |
| How does overexpression of MOCS3 affect Moco levels? | Overexpression of MOCS3 in mammalian cells |
| What is the subcellular localization of MOCS3? | Tagged knock-in of MOCS3 with fluorescent protein |
| Can small molecules modulate molybdopterin adenylyltransferase activity? | High-throughput screening using purified enzyme or cell-based assays |
How to Study the molybdopterin adenylyltransferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Enzyme activity assay | Adenylyltransferase activity | Characterization of wild-type and mutant MOCS3 |
| LC-MS/MS metabolomics | Levels of molybdopterin and adenylyl-molybdopterin | Diagnosis of Moco deficiency |
| CRISPR knockout screening | Genes affecting Moco biosynthesis | Identification of novel regulators |
| X-ray crystallography | Three-dimensional structure of enzyme-substrate complex | Mechanistic studies and drug design |
| Site-directed mutagenesis | Role of specific amino acids in catalysis | Structure-function analysis |
| Western blot | Protein expression levels | Validation of knockout or overexpression |
| Immunofluorescence | Subcellular localization | Determining organelle targeting |
| ATP consumption assay | ATP hydrolysis coupled to adenylation | Kinetic studies |
Enzymatic Activity Assays
The adenylyltransferase activity of MOCS3 can be measured in vitro using purified enzyme and substrates. Typically, the reaction is incubated with ATP and molybdopterin, and the formation of adenylyl-molybdopterin is detected by HPLC or mass spectrometry. Radioactive ATP can be used to monitor the transfer of the adenylate group. These assays are essential for characterizing mutant enzymes and screening inhibitors.
Metabolite Profiling
To assess the impact of molybdopterin adenylyltransferase activity on Moco biosynthesis, metabolite profiling can be performed. This involves measuring the levels of molybdopterin, adenylyl-molybdopterin, and other intermediates in cell extracts or body fluids using LC-MS/MS. Such profiling is used to diagnose Moco deficiency and to evaluate the efficacy of therapeutic interventions.
CRISPR-Based Genetic Screens
CRISPR knockout libraries can be used to identify genes that modulate molybdopterin adenylyltransferase activity or Moco biosynthesis. For example, a genome-wide screen could reveal synthetic lethal interactions with MOCS3 mutations. These screens are powerful for uncovering novel regulators and pathways.
Structural Biology
X-ray crystallography and cryo-EM can provide structural insights into the catalytic mechanism of molybdopterin adenylyltransferase. Structures of MOCS3 or its homologs bound to substrates or inhibitors can reveal key residues involved in catalysis and guide drug design. Such studies are complemented by mutational analysis.
How CRISPR Can Be Used to Study GO:0061598 molybdopterin adenylyltransferase activity
Knockout
CRISPR knockout of MOCS3 can be used to create cell models lacking molybdopterin adenylyltransferase activity. These cells are valuable for studying the consequences of Moco deficiency, such as impaired sulfite oxidase and xanthine dehydrogenase activities. Knockout cells can also be used to test the efficacy of gene therapy or small molecule treatments.
Point Mutation
CRISPR-mediated point mutations can introduce specific amino acid substitutions in MOCS3 to dissect its catalytic mechanism. For example, mutating conserved residues in the adenylyltransferase domain can abolish activity, while mutations in the rhodanese domain affect sulfur transfer. Such models help distinguish between the two functions of MOCS3.
Knock-in
Knock-in of tagged MOCS3 (e.g., with GFP or FLAG) allows for visualization and purification of the enzyme. This approach can also be used to express mutant variants under the endogenous promoter, providing more physiological relevance than overexpression. Knock-in models are useful for studying protein interactions and localization.
Overexpression
Overexpression of MOCS3 in mammalian cells can increase molybdopterin adenylyltransferase activity and Moco levels. This is useful for producing Moco-dependent enzymes for structural or biochemical studies. However, overexpression may lead to artifacts, so results should be validated with endogenous models.
How EDITGENE Supports molybdopterin adenylyltransferase activity Research
Researchers studying molybdopterin adenylyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in Moco biosynthesis or disease. EDITGENE provides a comprehensive suite of CRISPR services to create precisely engineered cell models, enabling functional validation and mechanistic studies.
Contact EDITGENE today to design your custom CRISPR model for molybdopterin adenylyltransferase activity research.
Frequently Asked Questions About molybdopterin adenylyltransferase activity
What is molybdopterin adenylyltransferase activity?
It is the enzyme activity that catalyzes the transfer of an adenylate group from ATP to molybdopterin, forming adenylyl-molybdopterin and diphosphate, as defined by GO:0061598.
What genes are involved in molybdopterin adenylyltransferase activity?
The primary gene in humans is MOCS3 (also known as UBA4), which encodes a bifunctional enzyme with adenylyltransferase and sulfur transfer activities.
What diseases are associated with molybdopterin adenylyltransferase activity?
Defects in this activity can lead to molybdenum cofactor deficiency, a severe metabolic disorder with neonatal seizures and neurological damage.
How is molybdopterin adenylyltransferase activity measured?
It is typically measured using in vitro enzyme assays with purified MOCS3, ATP, and molybdopterin, followed by detection of adenylyl-molybdopterin by HPLC or mass spectrometry.
What is the reaction catalyzed by molybdopterin adenylyltransferase?
The reaction is ATP + molybdopterin = diphosphate + adenylyl-molybdopterin.
Is molybdopterin adenylyltransferase activity conserved in bacteria?
Yes, the activity is conserved from bacteria to humans, with homologs such as MoaD and MoeB in bacteria.
What is the role of MOCS3 in molybdenum cofactor biosynthesis?
MOCS3 adenylates molybdopterin, a step required for molybdenum insertion and formation of the active cofactor.
Can CRISPR be used to study molybdopterin adenylyltransferase activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can be used to study the function of MOCS3 and its role in Moco biosynthesis.
What are the symptoms of molybdenum cofactor deficiency?
Symptoms include neonatal seizures, brain atrophy, developmental delay, and high sulfite levels in urine.
How does molybdopterin adenylyltransferase relate to FAD synthase?
Both enzymes catalyze adenylylation reactions and share structural similarities, making FAD synthase a model for understanding the mechanism.
Conclusion
Molybdopterin adenylyltransferase activity (GO:0061598) is a critical enzymatic step in molybdenum cofactor biosynthesis, enabling the activation of molybdopterin for molybdenum insertion. Its importance is underscored by the severe consequences of Moco deficiency, a disorder caused by defects in this pathway. Research into this activity not only sheds light on fundamental metabolic processes but also offers potential therapeutic targets for rare metabolic diseases. With advanced CRISPR tools and bioinformatics services from EDITGENE, researchers can create precise models to study this activity and accelerate discoveries.
References
- 1. Adam MP et al.. 1993. Molybdenum Cofactor Deficiency.. PMID: 34870926
- 3. Rizzi M et al.. 2002. Structural biology of enzymes involved in NAD and molybdenum cofactor biosynthesis.. Curr Opin Struct Biol 12(6):709-20 PMID: 12504674
- 5. Llamas A et al.. 2004. Synthesis of adenylated molybdopterin: an essential step for molybdenum insertion.. J Biol Chem 279(53):55241-6 PMID: 15504727
